Trial intelligence / Profile preview

Torasemide prolonged-release versus furosemide in hypertensive patients with heart failure

2006-001446-14Phase 4Completed

Sponsor
Ferrer
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in heart failure (HF) and hypertension (HTN) comparing Torasemide prolonged-release with Furosemide (2 arms). Primary endpoint: Serum procollagen type I carboxy-terminal peptide concentration. Started Mar 2012; status: completed.

02

Drugs

torasemidefurosemide
03

Conditions

heart failure (HF)hypertension (HTN)

Beyond the preview

Go deeper on 2006-001446-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001446-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call